Cbyrne11, as a clinical pharmacist, I can tell you that naturally-derived/plant-based medicines are able to largely by-pass the 'research+design' phase of 10-20 years because of regulatory loopholes. Furthermore, even if what you said was true, a superfluous amount of evidence already exists for its use in a myriad of conditions such as pain and epilepsy, albeit, they are the results of studies found in research performed by other countries - this does not discount the fact that their clinical trials are indeed valid for use regarding TGA's decisions; much the contrary as this allows a meta-analysis of randomised-controlled trials to be performed, which is, the GOLD STANDARD when it comes to releasing a new drug on the market. I can also tell you that the evidence for medicinal cannabis is overwhelming and it is only a matter of time before it becomes the next 'penicillin'.
- Forums
- ASX - By Stock
- RGT
- Ann: FDA Approval Granted and First US Distribution Deal Signed-MXC.AX
Ann: FDA Approval Granted and First US Distribution Deal Signed-MXC.AX, page-175
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RGT (ASX) to my watchlist
(20min delay)
|
|||||
Last
32.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.48M |
Open | High | Low | Value | Volume |
30.0¢ | 32.0¢ | 30.0¢ | $31.45K | 98.95K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 4674 | 30.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
36.0¢ | 4326 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 4674 | 0.305 |
2 | 3219 | 0.300 |
1 | 15000 | 0.260 |
1 | 20000 | 0.250 |
1 | 2200 | 0.230 |
Price($) | Vol. | No. |
---|---|---|
0.360 | 4326 | 1 |
0.365 | 11528 | 2 |
0.370 | 2000 | 1 |
0.380 | 1522 | 1 |
0.395 | 8746 | 1 |
Last trade - 12.44pm 05/09/2024 (20 minute delay) ? |
Featured News
RGT (ASX) Chart |